Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Advisor Group Holdings

<< Previous

Bullboard Posts

Next >>

Comment by Lee430on Aug 03, 2021 12:36pm

103 Views

Post# 33642627

RE:RE:RE:RE:RE:RE:RE:Advisor Group Holdings

Has anyone seen evidence that Thera is making a reasonable effort to engage the retail investors after Wino’s meeting representing us?

Wino115 wrote: There's so many reasons investors have to buy and sell that there is also something on offer either higher or lower. But we do know from our Board discussion that PL said a large Quebec institution felt the new "brand" introduced far too much risk for them. They didn't buy in the last offering, so maybe they're also selling as it rises. Rather dumb since they can walk down the street and get an incredibly detailed review of the science and assess the pipeline prospects. Institutional inertia is a huge problem in the investment business. There's also always index and tracker rebalancing and they are in a few of those indexes now. It won't be major, but then again the volumes aren't major either.

scarlet1967 wrote: Because of unmotivated investors, they try to bring individual investors onboard with all these behind closed doors talks. How about thousands of retail investors which need to be motivated?A multi marketing strategies will have multiple shots on their targets the sooner they start it the better imo.

Bucknelly21 wrote: Can someone answer this for me? Why does it always seem that whenever there is buying there always seems to be an equal amount of selling? I really have a hard time figuring out who keeps selling?